Taking advantage of clinically relevant prostate cancer patient cohorts with transcriptomic data ([30–32] and TCGA Firehose Legacy), we monitored the association of SRM mRNA expression with PGC1α transcriptional levels and activity [28]. This evidence concerns the gene PPARGC1A and prostate carcinoma.